SD
Stanley Druckenmiller (Duquesne Family Office) disclosed new in Twist Bioscience Corp
Stanley Druckenmiller (Duquesne Family Office) filed a 13F change in Twist Bioscience Corp (90184D100) on 2026-05-15, covering period end 2026-03-31.
Action
New
Capital
$9,789 reported value
Institutional 13F Signals1 evidence source
Why it matters
This signal is anchored to the SEC filing date while retaining the underlying 13F period end.